Implantica AG (OSTO:IMP A SDB) Beta: 1.2879 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IMP A SDB Implantica AG OSTO:IMP A SDB
25 GF Score
Price kr61.80
View Full Analysis

What is Implantica AG Beta?

Implantica AG OSTO:IMP A SDB +0.32% 25 Beta is 1.2879 as of Aug. 02, 2026. GuruFocus rates OSTO:IMP A SDB with a GF Score™ of 25/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-02), Implantica AG's Beta is 1.2879.


Implantica AG  (OSTO:IMP A SDB) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Implantica AG Beta Related Terms


Implantica AG Beta Historical Data

* Premium members only.

The historical data trend for Implantica AG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG Beta Chart

Implantica AG Annual Data
Trend
Beta

Implantica AG Semi-Annual Data
Beta

OSTO:IMP A SDB vs : Beta Comparison

For the Medical Devices subindustry, Implantica AG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Beta distribution charts can be found below:

* The bar in red indicates where Implantica AG's Beta falls into.


OSTO:IMP A SDB
25GF Score
Implantica AG OSTO:IMP A SDB
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implantica AG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.2879 mean?
Implantica AG (OSTO:IMP A SDB) has a Beta of 1.2879 as of Aug. 02, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Implantica AG and its competitors.
Is Implantica AG's Beta too high?
Implantica AG's current Beta is 1.2879. Overall, Implantica AG has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Beta compare to ?
Implantica AG's Beta of 1.2879 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Implantica AG and its competitors. Implantica AG's current Beta is 1.2879. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (OSTO:IMP A SDB) has a current Beta of 1.2879. The current Beta is 1.2879. Implantica AG's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Implantica AG (OSTO:IMP A SDB), the current Beta is 1.2879 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
25GF Score

Get the complete analysis for OSTO:IMP A SDB

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr61.80
Price